PO.TB10.08 · 肿瘤生物学
Basescope™ 双重检测法实现同片检测包括异构体在内的短RNA靶标
Basescope™ duplex assay enables same-slide detection of short RNA targets including isoforms
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景 哺乳动物基因的遗传改变,包括外显子跳跃和点突变,在肿瘤发生以及预测患者生存和疾病预后中发挥关键作用。研究表明,可根据基因转录本异构体将癌细胞系与非癌细胞系区分开。例如,MET(受体酪氨酸激酶)外显子14跳跃突变以及EGFR外显子19、21缺失或外显子20插入突变,已成为多种癌症类型中的生物标志物。此外,可变剪接在疾病进展和治疗反应中发挥关键作用。基因异构体的空间可视化有望更好地理解肿瘤微环境。
方法 我们在Leica平台上开发了新一代手动和全自动荧光检测法,能够特异且同时检测高度相似的RNA靶标——异构体特异性外显子-外显子连接。该检测法利用RNAscope™技术的特异性和灵敏度,在福尔马林固定石蜡包埋(FFPE)组织和细胞团块上可视化单个RNA分子。为验证新工作流程,使用1zz探针在HeLa细胞团块和小鼠多组织芯片上检测内源性对照基因。将信号和背景与原始BaseScope 1zz探针进行了定量比较。为可视化MET外显子14跳跃(METΔ14),在WT和变异阳性细胞团块上检测了MET WT外显子和外显子14-15连接特异性探针。此外,使用采用简化RNAscope化学、可潜在共检测mRNA、蛋白和蛋白-蛋白相互作用的BaseScope双重检测法,将外显子13-15或外显子14-15连接探针与外显子15探针双重化,分别在MET WT和Δ14细胞团块中共检测。
结果 使用新BaseScope技术从对照基因获得的信号(以每个细胞的点计数确定)与使用原始BaseScope检测法产生的信号相当。接下来,我们使用双荧光基团在同一张切片上鉴定两种异构体,可视化了MET突变团块上METΔ14外显子连接探针的特异信号以及WT细胞团块上WT MET探针的特异信号。在WT团块中未观察到突变探针的信号,表明该检测法的特异性。同样,将MET外显子14-15连接探针与外显子15探针在检测中双重化,并在野生型细胞团块上使用两种不同的荧光基团进行可视化。将外显子13-15连接探针与外显子15探针双重化,并在突变细胞团块上使用两种荧光基团共检测。这些结果证明了该检测法在同片检测表达两种短靶标的细胞方面的功效。
结论 该BaseScope双重检测法提供了异构体和点突变特异性基因表达的空间分辨率,为探索肿瘤微环境内细胞特异性转录本变异提供了强大工具,并有望推动精准肿瘤学研究。
查看英文原文 English abstract
Background Genetic changes in mammalian genes including exon skipping and point mutations play a crucial role in oncogenesis and predicting patient survival and disease prognosis. Studies have shown that cancer cell lines can be distinguished from non-cancer cell line based on gene transcript isoform. As example, MET (receptor tyrosine kinase) exon 14 skipping mutation and EGFR exon 19, 21 deletion or exon 20 insertion mutation have emerged as a biomarker in various cancer types. Additionally, alternative-splicing plays a crucial role in disease progression and therapeutic response. Spatial visualization of gene isoform holds the potential of providing better understanding of tumor microenvironment.
Methods We developed a next-generation, manual and fully automated fluorescent assays on the Leica platform that enables specific and simultaneous detection of highly similar RNA targets - isoform-specific exon-exon junctions. The assay utilizes specificity and sensitivity of RNAscope TM technology to visualize single RNA molecule on formalin fixed paraffin embedded (FFPE) tissue and cell pellets. To validate the new workflow, endogenous control genes were detected using 1zz probes on HeLa cell pellets and Mouse multi tissue array. Signal and background were quantitatively compared to original BaseScope 1zz probes. To visualize MET exon 14 skipping (METΔ14), MET WT exon and exon 14-15 junction specific probes were detected on the WT and variant positive cell pellets. Further, exon 13-15 or exon 14-15 junction probe and exon 15 probes were duplexed and co-detected in MET WT and Δ14 cell pellets, respectively using BaseScope duplex assay that utilizes streamlined RNAscope chemistry to potentially co-detect mRNAs, proteins and protein-protein interactions.
Results Signal (as determined by dot counts/cell) from control gene using new BaseScope technology was comparable to signal generated using original BaseScope assay. Next, we visualized specific signal from METΔ14 exon junction probe on MET mutant pellet and WT MET probe on WT cell pellet, using dual fluorophores to identify both isoforms on the same slide. No signal was observed from mutant probe in WT pellet indicating specificity of the assay. Similarly, MET exon 14-15 junction probe and exon 15 probes were duplexed in the assay and visualized using two distinct fluorophores on wild-type cell pellet. Exon 13-15 junction probe and exon 15 probe were duplexed and co-detected using two fluorophores on mutant cell pellet. These results demonstrate the assay's efficacy in same-slide detection of cells expressing two short targets.
Conclusions This BaseScope Duplex assay provides spatial resolution of isoform and point mutation-specific gene expression, offering a powerful tool for exploring cell-specific transcript variants within the tumor microenvironment and potentially advancing precision oncology research.
利益披露 Disclosure
S. A. Deshpande, None..
A. J. Y. Ling, None..
J. Yu, None..
A. Dikhshit, None..
L. Wang, None.